Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-Dose Dexamethasone in High Pain Responders for Hip Arthroplasty
NCT03763760Phase 4Completed
- Sponsor
- Rigshospitalet
- Start
- Jan 2019
- Primary completion
- Jan 2021
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of dexamethasone in postoperative pain (2 arms), sponsored by Rigshospitalet. Primary endpoint: Postoperative pain after 24 hours: VAS. Started Jan 2019; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03763760.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03763760.